Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodies

Therapeutic low density lipoprotein-related protein 6 (LRP6) multivalent antibodies

US Patent 9290573 · Granted Mar 22, 2016

Estimated economic value: $9,484,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-TCR antibody molecules and uses thereof2025
Multispecific antibody molecules comprising lambda and kappa light chains2025
Methods of treating cancer with anti-PD-1 antibodies2025
Antibody molecules that bind to NKP30 and uses thereof2025
Anti-interleukin-23 P19 antibodies and methods of use thereof2025
Multifunctional molecules that bind to T cell related cancer cells and uses ther2025
Anti-TCR antibody molecules and uses thereof2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Thermophilic recombinant type II pullulanase and application thereof2025
Antibody or chimeric antigen receptor which targets Claudin 18.22025